PACS Group, Inc. (PACS) Stock

PACS Group, Inc. (PACS) is a Healthcare stock trading at $43.92 (as of 2026-08-25), with a market capitalization of $6.95B and a trailing P/E of 23.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

PACS Group, Inc. is a holding company, which engages in the provision of post-acute healthcare facilities, professionals, and ancillary services. It provides senior care, assisted living, and independent living options in some of the communities. The company was founded by Jason Murray and Mark Hancock in 2013 and is headquartered in Farmington, UT.

Understand PACS Group, Inc.: how it makes money

PACS Group operates skilled nursing, assisted living, and independent living communities, earning per-diem reimbursement from Medicare, Medicaid, and private payers for patient and resident care. The business is a per-day volume play: revenue scales with occupied beds and the share of those days billed at higher skilled-nursing rates, while government-set reimbursement levels cap the price per day.

Every occupied skilled-nursing bed generates a fixed daily per-diem fee from a government or private payer, so facility-level profit is simply (occupancy × skilled mix × daily rate) minus labor and overhead, with no pricing discretion.

Business quality (Mixed): The per-diem model produces real but thin earnings (8% operating margin on $1.4B quarterly revenue) and trades at a modest discount to peers. Quality is mixed: the revenue stream is recurring, yet the margin leaves almost no buffer against reimbursement or labor-cost shocks.

Valuation: At 23× earnings, PACS trades 8% below the Healthcare Services average (25×).

Bull case

  • Trading below industry valuation: At a P/E of 23.4x versus the Healthcare Services industry average of 25x (8% below), PACS carries a modest valuation discount. If mature-facility execution keeps the per-diem engine stable, the multiple has room to converge toward the peer set.
  • Recurring per-diem revenue model: Quarterly revenue of $1.4B is generated from daily patient and resident service fees paid by Medicare, Medicaid, and private insurers, making cash flow inherently recurring as long as beds stay occupied. The model does not depend on episodic demand or product cycles.

Bear case

  • Eight percent leaves no cushion: An 8% operating margin on a labor-intensive, facility-level cost structure means even a moderate spike in nursing wages or a small occupancy dip can push individual facilities toward breakeven. The model has almost no shock absorber before earnings are materially affected.
Valuation — source: SEC EDGAR (first-party)
Price$43.92
Market Cap$6.95B
P/E Ratio23.4
EV / EBITDA15.8
Price / Book6.23
Price / Sales1.24
DCF Value (model)$22.32
DCF Upside vs Price-49.2%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$5.29B
Net Margin3.6%
Revenue Growth (YoY)9.1%
EPS Growth (YoY)45.5%
Financial Health — source: SEC EDGAR
Altman Z-Score2.12 (grey)
Valuation vs Sector & Industry
Stock P/E23.4
Sector P/E (Healthcare)21.9
Industry P/E (Healthcare Services)25.4
vs Sector6.6%
vs Industry-8.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderCOHEN & STEERS, INC. ($293.04M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryHealthcare Services
CEOJason Murray
Employees32,433
CountryUS
IPO Date2024-04-11

Related Companies (Healthcare Services; 8 comparable companies)

  • The Ensign Group, Inc. (ENSG)
  • National HealthCare Corporation (NHC)
  • Select Medical Holdings Corporation (SEM)
  • Option Care Health, Inc. (OPCH)
  • Agilon Health, Inc. (AGL)
  • Encompass Health Corporation (EHC)
  • Ardent Health Partners, LLC (ARDT)
  • Acadia Healthcare Company, Inc. (ACHC)
PACS earnings history · PACS institutional & insider holders · PACS KPIs & operating metrics · PACS financials · PACS investor presentations & press releases · PACS SEC filings · PACS peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-25.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.